{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-029935","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2022-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.162587+00:00","generated_at":"2026-06-21T18:47:15.320006+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"Oncology Institute announces Q3 2022 results and FY2022 guidance via slide deck","bullets":["Slide presentation includes financial results for three and nine months ended Sept 30, 2022.","Company provided updated business guidance for the year ending Dec 31, 2022.","Presentation issued on Nov 15, 2022; common stock (TOI) and warrants (TOIIW) traded on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-029935","json":"https://secwatch.observer/filing/0001628280-22-029935.json","markdown":"https://secwatch.observer/filing/0001628280-22-029935.md","text":"https://secwatch.observer/filing/0001628280-22-029935.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022029935/0001628280-22-029935-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022029935/toi-20221115.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T18:47:15.320006+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5dd7110e15432fd46e6ed1805c1d605d9c6a97b8","claim":"Oncology Institute, Inc. reported financial results for three and nine months ended September 30, 2022.","evidence_excerpt":"Item 2.02. Results of Operations and Financial Condition On November 15, 2022, The Oncology Institute, Inc. (the \"Company\") issued a slide presentation which includes the Company's financial results for the three and nine months ended September 30, 2022 and certain other financial information. A copy of the presentation is furnished hereto as Exhibit 99.1, which are incorporated by reference herein.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022029935/0001628280-22-029935-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and nine months ended September 30, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}